Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Certain drugs can change hair color, either lightening or darkening it.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Biopsy is crucial to correctly diagnose granuloma annulare, which can mimic other conditions like alopecia mucinosa.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.